1-Azido-4-nitrobenzene 0.1M in MeTHF 100mg = 6.25mL solution, 97.0%, 100mg

(S)-N-(2-(4-Isobutyl-4,5-dihydrooxazol-2-yl)phenyl)quinoline-2-carboxamide, 100mg

(S)-3-(Methoxymethyl)morpholine hydrochloride, 95.0%, 250mg

Ethyl (3S,4R)-1-(tert-butyl)-4-(2,4-difluorophenyl)pyrrolidine-3-carboxylate, 95%, 250mg

4-[(4-Aminophenyl)sulfonyl]piperazin-2-one, 90.0%, 500mg

3-Methyl-1H-pyrazolo[3,4-b]pyridine, 95.0%, 10g

tert-Butyl 1-(Tosyloxy)-3,6,9,12-tetraoxapentadecan-15-oate, >98.0%(HPLC)(T), 5g

6-Bromo-1H-indol-3-yl acetate, 95.0%, 5g

p-Toluenesulfonyl Isocyanate>95.0%(T)100g

5-(2-Nitro-phenyl)-furan-2-carbaldehyde, 250mg

4-(5-amino-1,3,4-oxadiazol-2-yl)phenol, 95.0%, 5g

3-Cyclopropyl-1H-pyrazol-5-amine, 96.0%, 25g

tert-butyl ((1R,3S)-3-acetylcyclopentyl)carbamate compound with tert-butyl ((1S,3R)-3-acetylcyclopentyl)carbamate, 97%, 250mg